SCHEMBL2552199

SCHEMBL2552199

Clc1cccc2c1C=Nc1ccccc1N2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
USP2 O75604 1/20 0.40
PPARG P37231 1/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NR2E3 Q9Y5X4 1/20 0.40
NCOR2 Q9Y618 1/20 0.40
ALDH1A1 P00352 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
MAPT P10636 4/20 0.36
KDM4E B2RXH2 1/20 0.36
TP53 P04637 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
HTR5A P47898 5/20 0.35
HTR1A P08908 3/20 0.35
HTR1D P28221 3/20 0.35
HTR2C P28335 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1773148 0.79 MEN1 (0.40) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL1773151 0.79 MEN1 (0.40) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL5259226 0.79 KMT2A (0.40) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL8203048 0.76 MEN1 (0.38) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL309794 0.71 MAPT (0.50) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL5445017 0.71 CHRM1 (0.49) MEN1KMT2AUSP2HSD17B10SMN1; SMN2
SCHEMBL311435 0.70 TRPA1 (0.55) MEN1KMT2ASMN1; SMN2MAPTTP53
SCHEMBL6029951 0.69 HTR1A (0.44) HSD17B10ALDH1A1KDM4EHTR5AHTR1A
SCHEMBL1132587 0.69 TRPA1 (0.40) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL1726796 0.69 TRPA1 (0.56) HTR1AHTR2CHTR2AHTR3AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011123678-A2 SUBSTITUTED BENZO-PYRIDO-TRIAZOLO-DIAZEPINE COMPOUNDS ARQULE, INC. (US) 2011-10-06 WO disclosed